Transcutaneous Analyte Measuring Methods (TAMM Phase 2).
Quarterly progress rept. no. 4,
BIOTRONICS TECHNOLOGIES INC WAUKESHA WI
Pagination or Media Count:
The major objective of this extended quarter was to complete the analysis of pre-clinical data collected at the National Naval Medical Center NNMC in Bethesda, Maryland for the purposes of accuracy evaluation and algorithm development so as to allow for the initiation of field instrument development. Data on the first 250 patients were collected at the Bethesda NNMC beginning on June 23, 1992 during two separate time periods. Testing was completed on August 4th. All patients were military personnel undergoing physical examinations. This patient group was selected to be representative of combat age military personnel. Meanwhile, testing of the second group of 250 patients began at Froedtert Lutheran Memorial Hospital in Milwaukee on September 9, 1992 in conjunction with the Department of Endocrinology and the Shared Clinic of the Medical College of Wisconsin. Patients tested are people with various medical problems that were being treated on an out-patient basis. Testing will be completed on or about November 30th.
- Medicine and Medical Research
- Numerical Mathematics